Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
CDXS
#3293
Codexis, Inc.
1.0
1
-5.61%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-5.61%
Monatliche Änderung
-30.82%
6 month change
-62.31%
Jahresänderung
-71.14%
Vorheriger Schlusskurs
1.0
7
Open
1.0
1
Bid
Ask
Low
1.0
1
High
1.0
1
Volumen
54
Märkte
Aktien
Gesundheitswesen
CDXS
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
64.4 M
65.16 M
65.95 M
70.3 M
82.84 M
—
Valuation ratios
Enterprise value
1.26 B
1.92 B
193.97 M
154.25 M
375.87 M
968.94 M
Price to earnings ratio
—
-94.76
-9.16
-2.79
-5.36
-14.37
Price to sales ratio
—
19.27
2.2
3.03
5.9
16.88
Price to cash flow ratio
—
141.52
27.04
4.04
7.09
17.37
Price to book ratio
—
12.28
2.11
2.45
5.23
7.73
Enterprise value to EBITDA ratio
-57.1
-94.77
-6.57
-2.85
-7
-17.53
Profitability ratios
Return on assets %
-0.11
-0.09
-0.13
-0.56
-0.44
-0.48
Return on equity %
-0.14
-0.13
-0.23
-0.88
-0.98
-1.32
Return on invested capital %
-173.5
-103.83
-119.26
-292.06
-347.28
-137.1
Gross margin %
80.04
78.47
72.52
81.74
72.55
304.41
Operating margin %
-34.64
-21.67
-25.17
-97.04
-98.61
-169.39
EBITDA margin %
-31.87
-19.35
-21.31
-77.17
-90.44
-565.99
Net margin %
-34.77
-20.31
-24.24
-108.69
-109.99
-637.26
Liquidity ratios
Quick ratio
7.34
4.82
3.28
2.53
4.1
17.45
Current ratio
7.38
4.85
3.32
2.61
4.18
17.85
Inventory turnover
20.59
20.91
23.85
5.43
7.26
5.8
Asset turnover
0.37
0.45
0.56
0.36
0.42
0.38
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.19
1.03
Long term debt to total equity ratio
—
—
—
—
0.43
2.76
Per share metrics
Operating cash flow per share
—
-0.22
0.17
-0.77
-0.67
-0.7
EBIT per share
—
-0.36
-0.53
-0.88
-0.8
-0.72
EBITDA per share
—
-0.31
-0.45
-0.79
-0.73
-0.66
Total debt per share
—
—
—
—
—
—
Cash per share
—
1.81
1.74
0.96
1
3.2
Net current asset value per share
—
2.51
2.49
1.37
1.35
4.23
Tangible book value per share
—
2.5
2.17
1.24
0.88
2.5
Working capital per share
—
1.99
1.74
0.85
1.02
3.26
Book value per share
—
2.55
2.22
1.27
0.91
2.62
Codexis Inc
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
Nachrichten
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates
Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Beats Revenue Estimates
Incyte (INCY) Q4 Earnings Lag Estimates
Codexis CSO Stefan Lutz sells $7949 in shares
Opaleye management sells Codexis (CDXS) shares for $1.87 million
Opaleye management sells Codexis (CDXS) shares worth $877,846
Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS)
Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates
Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Beats Revenue Estimates
Codexis (CDXS): CTO Alison Moore veräußert Aktienpaket im Wert von 15.629 $